Improving Bone Marrow Transplant Outcomes with Educational Sleep Intervention
Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation (DREAM-BMT)
This study is testing whether an educational program about sleep can help adults getting a bone marrow transplant feel better compared to just the usual care they receive.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Scripps Health Academic / other |
| Locations | 1 site (San Diego, California) |
| Trial ID | NCT06590285 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness and safety of an educational sleep intervention compared to standard care for adults undergoing allogeneic hematopoietic stem cell transplantation (alloHSCT). It involves randomizing eligible patients to receive either the app-based educational intervention or standard care. The study aims to enhance patient outcomes by providing tailored educational resources to improve sleep quality during the transplant process. Screening and randomization will occur in the patient's home environment to facilitate participation.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 or older who are planning to undergo alloHSCT and have access to a digital device for the study app.
Not a fit: Patients who have failed a prior alloHSCT within the past 6 months may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of life and recovery outcomes for patients undergoing bone marrow transplantation.
How similar studies have performed: While the specific educational sleep intervention is novel, similar studies have shown that educational approaches can improve patient outcomes in transplant settings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female patients aged 18 or older at the time of study informed consent. * Have plan to undergo alloHSCT from any donor source using bone marrow, peripheral blood stem cells, or cord blood. Recipients of non-myeloablative, myeloablative and reduced intensity conditioning are eligible. * Patients have access to digital device capable of downloading study app * Patients able to read study documents and able to complete informed consent within the study app Exclusion Criteria: * Failed prior alloHSCT within the past 6 months
Where this trial is running
San Diego, California
- Scripps Health — San Diego, California, United States (Recruiting)
Study contacts
- Principal investigator: Jake New, MD, PhD — Scripps Clinic
- Study coordinator: Jake New, MD, PhD
- Email: new.jacob@scrippshealth.org
- Phone: 858-784-2701
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.